HUP0204209A2 - Készítmények lipidmetabolizmus-rendellenességek és allergiás formák megelőzésére és/vagy kezelésére - Google Patents

Készítmények lipidmetabolizmus-rendellenességek és allergiás formák megelőzésére és/vagy kezelésére

Info

Publication number
HUP0204209A2
HUP0204209A2 HU0204209A HUP0204209A HUP0204209A2 HU P0204209 A2 HUP0204209 A2 HU P0204209A2 HU 0204209 A HU0204209 A HU 0204209A HU P0204209 A HUP0204209 A HU P0204209A HU P0204209 A2 HUP0204209 A2 HU P0204209A2
Authority
HU
Hungary
Prior art keywords
prevention
treatment
lipid metabolism
metabolism disorders
composition
Prior art date
Application number
HU0204209A
Other languages
English (en)
Inventor
Pietro Pola
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of HUP0204209A2 publication Critical patent/HUP0204209A2/hu
Publication of HUP0204209A3 publication Critical patent/HUP0204209A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány lipidmetabolizmus-rendellenességek és allergiás formákmegelőzésére és/vagy kezelésére, valamint immunvédekezés aktiválásáraalkalmas, táplálékkiegészítőként vagy gyógyszer formájábanalkalmazható készítményre vonatkozik. A találmány szerinti kombinációskészítmény jellemző összetevőkként a) izovaleril-L- karnitint vagygyógyászatilag elfogadható sóját és b) foszforilezett, glikozilezettvagy aminált glükánok és galaktánok, vagy ezek keverékei közülválasztott poliszacharidot tartalmaz. Ó
HU0204209A 2000-11-17 2001-07-24 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms HUP0204209A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000602A IT1317938B1 (it) 2000-11-17 2000-11-17 Composizione per la prevenzione e/o il trattamento di alterazioni delmetabolismo lipidico, delle forme allergiche e per attivare le difese
PCT/IT2001/000394 WO2002040012A1 (en) 2000-11-17 2001-07-24 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms

Publications (2)

Publication Number Publication Date
HUP0204209A2 true HUP0204209A2 (hu) 2003-04-28
HUP0204209A3 HUP0204209A3 (en) 2005-03-29

Family

ID=11455002

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204209A HUP0204209A3 (en) 2000-11-17 2001-07-24 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms

Country Status (19)

Country Link
US (1) US7211571B2 (hu)
EP (1) EP1257267B1 (hu)
AT (1) ATE269073T1 (hu)
AU (1) AU778952B2 (hu)
CA (1) CA2406925A1 (hu)
CZ (1) CZ20022307A3 (hu)
DE (1) DE60103854T2 (hu)
DK (1) DK1257267T3 (hu)
ES (1) ES2222388T3 (hu)
HU (1) HUP0204209A3 (hu)
IL (1) IL150637A0 (hu)
IT (1) IT1317938B1 (hu)
MX (1) MXPA02007001A (hu)
NO (1) NO20023117L (hu)
PL (1) PL355200A1 (hu)
PT (1) PT1257267E (hu)
SK (1) SK10282002A3 (hu)
TR (1) TR200401572T4 (hu)
WO (1) WO2002040012A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
EA034552B1 (ru) 2009-05-11 2020-02-19 БЕРГ ЭлЭлСи Способ лечения или предотвращения прогрессирования онкологических заболеваний
ES2762451T3 (es) 2011-04-04 2020-05-25 Berg Llc Tratamiento de tumores del sistema nervioso central con coenzima Q10
JP6731336B2 (ja) 2013-04-08 2020-07-29 バーグ エルエルシー コエンザイムｑ１０併用療法を用いた癌の処置方法
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975421A (en) * 1985-08-19 1990-12-04 Bioglucan, Lp. Soluble phosphorylated glucan: methods and compositions for wound healing
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
PT951909E (pt) * 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
IL149907A0 (en) 1999-12-16 2002-11-10 Mark Nutritionals Inc Nutritional composition, methods of producing said composition and methods of using said composition

Also Published As

Publication number Publication date
IL150637A0 (en) 2003-02-12
TR200401572T4 (tr) 2004-09-21
US7211571B2 (en) 2007-05-01
PT1257267E (pt) 2004-09-30
DE60103854T2 (de) 2005-07-14
IT1317938B1 (it) 2003-07-15
DE60103854D1 (de) 2004-07-22
NO20023117D0 (no) 2002-06-27
SK10282002A3 (sk) 2003-03-04
HUP0204209A3 (en) 2005-03-29
CA2406925A1 (en) 2002-05-23
MXPA02007001A (es) 2003-01-28
PL355200A1 (en) 2004-04-05
ITRM20000602A1 (it) 2002-05-17
AU778952B2 (en) 2004-12-23
WO2002040012A1 (en) 2002-05-23
US20030017999A1 (en) 2003-01-23
DK1257267T3 (da) 2004-10-25
ES2222388T3 (es) 2005-02-01
AU7667501A (en) 2002-05-27
ATE269073T1 (de) 2004-07-15
NO20023117L (no) 2002-06-27
EP1257267A1 (en) 2002-11-20
ITRM20000602A0 (it) 2000-11-17
CZ20022307A3 (cs) 2003-01-15
EP1257267B1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
EP2123282A3 (en) Immunemodulating oligosaccharides
MY143795A (en) Tetrahydropyridoindole derivatives
WO2005102301A3 (en) Hydroxymethylbutyrate compositions and uses thereof
HUP0204546A2 (en) Carbohydrate formulation for enhancement of immune response
WO2002047703A8 (en) Immune system stimulation
WO2006002909A3 (en) Sphingolipids against pathological processes in lipid rafts
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
WO2006053761A3 (en) Modified plant gums for preparations of active ingredients
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
WO2005082927A3 (en) Antihypertensive peptides
UA88165C2 (en) Use of trisubstituted benzopyranones
AU4073901A (en) Novel pharmaceutical or dietetic mushroom-based compositions
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
CA2412789A1 (en) Compositions for improving mental concentration
HUP0204209A2 (hu) Készítmények lipidmetabolizmus-rendellenességek és allergiás formák megelőzésére és/vagy kezelésére
PT1796702E (pt) Utilização de óleo de lavanda para profilaxia e tratamento de distúrbios de somatização e da doença de stress pós-traumático
WO2005018542A3 (en) Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
WO2004006911A3 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
AR045745A1 (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2
PT1768682E (pt) Produto de origem vegetal compreendendo proantocianidinas e seu processo de preparação
HUP0401940A2 (hu) Diabetikus neuropátia esetében alkalmazható gyógyszerkészítmény
WO2003026693A3 (en) Inhibitors of costimulation by 0x40 and their use against infectious diseases

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees